EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 22 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | -100.0% | 1,074 | +360.9% | 0.00% | – |
| Q1 2016 | $1,000 | – | 233 | +55.3% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 150 | -90.9% | 0.00% | – |
| Q3 2015 | $7,000 | -36.4% | 1,650 | -9.1% | 0.00% | – |
| Q2 2015 | $11,000 | -71.1% | 1,816 | -58.0% | 0.00% | – |
| Q1 2015 | $38,000 | +72.7% | 4,328 | +14.4% | 0.00% | – |
| Q4 2014 | $22,000 | +214.3% | 3,783 | +273.4% | 0.00% | – |
| Q3 2014 | $7,000 | – | 1,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|